Detailed Mechanism Funding and Narrative

Years of mechanism: 2008 2009

Details for Mechanism ID: 1353
Country/Region: Botswana
Year: 2008
Main Partner: Harvard University
Main Partner Program: Harvard School of Public Health
Organizational Type: University
Funding Agency: HHS/HRSA
Total Funding: $2,786,962

Funding for Treatment: Adult Treatment (HTXS): $2,786,962

08.T1111-Central: Harvard Botswana AIDS Initiative Partnership

The BHP-PEPFAR ART Training and Site Support program is aimed at developing sustainable training

capacity in clinical care and treatment of HIV/AIDS patients, expanding CD4 and Viral load laboratory

testing to decentralized laboratories, and strengthening the Botswana MOHs M&E capacity to monitor the

effectiveness of the National ART program (MASA).

Achievements during FY07

Clinical master trainer results (CMT): Number of health personnel trained for ART services - 492, number

trained in palliative care - 635, facilities supported and mentored - 18 hospitals and 39 satellite clinics.

Laboratory Master Trainer (LMT) results: Number of lab technicians trained - 22; facilities supported and

mentored -15; decentralized laboratories supported ran 72,041 samples for CD4 testing, and 7,577 for VL

testing

Monitoring and Evaluation (M&E) results: Sites reached - 32; data entry clerks (DEC) trained - 59; data

warehouse developed; integration of MASA and DHIS ongoing and; data security and confidentiality

system to encrypt and decrypt completed.

Plans for FY2008:

A) CMT will continue to:

1) task shifting: training of nurse dispensers and nurse pre scribers; 2) train Health Care Providers on QAI

and implementation of QA activities at ART site level and QAI training for district/site leadership cadres; 3)

provide CME at district level, telephone site support; 4) continue training material development, SOP's,

guidelines, memo's and checklists tools for care and treatment sites.

B) LMT will continue to:

1) support the established CD4, VL decentralized and expand training to include hematology, chemistry and

microbiology support; 2) in collaboration with MOH and HHS/CDC/BOTUSA formalize the training manuals

on CD4, VL, hematology, chemistry and microbiology (including TB); 3) train on LIS issues at decentralized

labs/sites and train on lab data management, reagent logistics and quality assurance.

C) The M&E Unit within Masa will continue to:

1) refine and expand indicators and management tools; 2) replace PIMS (MASA) and roll out new system to

all PIMS locations; 3) integrate functions of (e.g. PMTCT) and integrate with all other national systems (e.g.

DHIS); 4) train end users on the new systems; 5) establish support desk and using DEC to perform vital

role; 6) conduct a targeted patient evaluation study on medication adherence.